Prospectus approuvés par la FSMA à partir du 1er mars 2021 (Système de reporting Règlement Prospectus 2017/1129)
| Date | Emetteur | Type d'instrument de placement | Type de document | Etats membres d'accueil | Document |
|---|---|---|---|---|---|
| 05/03/2024 | BELFIUS BANQUE | PIII - Non applicable | Supplément au prospectus | SUPP-20242204-EN-DOCREG-2024-000043-02.pdf | |
| 05/03/2024 | BELFIUS BANQUE | PIII - Non applicable | Supplément au prospectus | SUPP-20242204-EN-DOCREG-2024-000046-02.pdf | |
| 05/03/2024 | U C B | PIII - Non applicable | Supplément au prospectus | Luxembourg |
SUPP-20241403-EN-DOCREG-2024-000069-02.pdf |
| 05/03/2024 | uFund | Divers | Prospectus complet | 2024-(1128)-FR-SCS20240024-A01-B25-C01-NP-CD05_03.pdf | |
| 27/02/2024 | PROXIMUS | PIII - Non applicable | Supplément au prospectus | SUPP-20242902-EN-DOCREG-2024-000052-02.pdf | |
| 13/02/2024 | KBC Groupe | PIII - Non applicable | Supplément au prospectus | SUPP-20241402-EN-DOCREG-2024-000028-02.pdf | |
| 07/02/2024 | Celyad Oncology | Actions | Document d'enregistrement, Note d'opération et résumé | France |
SECN-20241502-EN-DOCREG-2024-000026-03.pdf REGN-20241502-EN-DOCREG-2024-000026-03.pdf SMRY-20241502-EN-DOCREG-2024-000026-03.pdf |
| 07/02/2024 | ING BELGIQUE | PIII - Non applicable | Supplément au prospectus | SUPP-20240902-EN-DOCREG-2024-000012-02.pdf | |
| 05/02/2024 | BioSenic | Actions | Note d'opération et résumé | France |
SECN-20240702-EN-DOCREG-2024-000022-03.pdf SMRY-20240702-FR-DOCREG-2024-000022-03.pdf |
| 23/01/2024 | BioSenic | Actions | Note d'opération et résumé | France |
SMRY-20242501-FR-DOCREG-2024-000016-03.pdf SECN-20242501-EN-DOCREG-2024-000016-03.pdf |
| 20/12/2023 | CRELAN | PIII - Non applicable | Supplément au prospectus | SUPP-20232712-EN-DOCREG-2023-000488-02.pdf | |
| 20/12/2023 | ING BELGIQUE | PIII - Non applicable | Prospectus de base | BPWO-20241501-EN-DOCREG-2023-000458-02.pdf | |
| 20/12/2023 | Eyeworks Film & TV Drama | Divers | Prospectus complet | 2023-(123)-NL-SCS20230318-A01-B25-C01-NP-CD20_12.pdf | |
| 20/12/2023 | Scope Invest | Divers | Prospectus complet | 2023-(1041)-FR-SCS20230304-A01-B25-C01-NP-CD20_12.pdf | |
| 20/12/2023 | Taxshelter.be SA | Divers | Supplément au prospectus | 2023-(1151)-FR-SCS20230329-A01-B25-C11-NP-CD20_12.pdf | |
| 19/12/2023 | Fluvius System Operator | PIII - Non applicable | Supplément au prospectus | SUPP-20240201-EN-DOCREG-2024-000001-02.pdf | |
| 06/12/2023 | BELFIUS BANQUE | PIII - Non applicable | Prospectus de base | BPWO-20231512-EN-DOCREG-2023-000247-02.pdf | |
| 06/12/2023 | Casa Kafka Pictures | Divers | Supplément au prospectus | 2023-(1102)-FR-SCS20230319-A01-B25-C11-NP-CD06_12.pdf | |
| 15/11/2023 | Oxurion | Actions | Supplément au prospectus | SUPP-20231611-EN-DOCREG-2023-000453-03.pdf | |
| 15/11/2023 | SYENSQO | Actions | Note d'opération et résumé | France |
SMRY-20231611-EN-DOCREG-2023-000457-03.pdf SECN-20231611-EN-DOCREG-2023-000457-03.pdf |
| 15/11/2023 | KBC Groupe | PIII - Non applicable | Supplément au prospectus | SUPP-20231611-EN-DOCREG-2023-000455-02.pdf | |
| 15/11/2023 | SYENSQO | PIII - Non applicable | Supplément au prospectus | France |
SUPP-20231611-EN-DOCREG-2023-000456-02.pdf |
| 09/11/2023 | ATENOR | Actions | Prospectus complet | STDA-20231311-EN-DOCREG-2023-000447-03.pdf | |
| 06/11/2023 | PROXIMUS | PIII - Non applicable | Supplément au prospectus | SUPP-20230711-EN-DOCREG-2023-000443-02.pdf | |
| 06/11/2023 | BioSenic | Actions | Note d'opération et résumé | France |
SMRY-20230711-EN-DOCREG-2023-000441-03.pdf SECN-20230711-EN-DOCREG-2023-000441-03.pdf |
| 06/11/2023 | uFund | Divers | Supplément au prospectus | 2023-(1128)-FR-SCS20230298-A01-B25-C11-NP-CD06_11.pdf | |
| 24/10/2023 | BELFIUS BANQUE | PIII - Non applicable | Prospectus de base | BPWO-20230112-EN-DOCREG-2023-000388-02.pdf | |
| 24/10/2023 | U C B | PIII - Non applicable | Supplément au prospectus | SUPP-20230611-EN-DOCREG-2023-000437-02.pdf | |
| 24/10/2023 | CBC Banque | PIII - Non applicable | Prospectus de base | BPWO-20232610-EN-DOCREG-2023-000316-02.pdf | |
| 24/10/2023 | KBC Bank | PIII - Non applicable | Prospectus de base | BPWO-20232610-EN-DOCREG-2023-000316-02.pdf | |
| 24/10/2023 | CRELANCO | Actions | Supplément au prospectus | SUPP-20230611-FR-DOCREG-2023-000436-03.pdf | |
| 17/10/2023 | U C B | PIII - Non applicable | Prospectus de base | BPWO-20232310-EN-DOCREG-2023-000422-02.pdf | |
| 03/10/2023 | Oxurion | Actions | Supplément au prospectus | SUPP-20230410-EN-DOCREG-2023-000403-03.pdf | |
| 03/10/2023 | Mithra Pharmaceuticals | Actions | Supplément au prospectus | SUPP-20230410-EN-DOCREG-2023-000403-03.pdf | |
| 03/10/2023 | Mithra Pharmaceuticals | Actions | Supplément au prospectus | SUPP-20230410-EN-DOCREG-2023-000403-04.pdf | |
| 02/10/2023 | BELFIUS BANQUE | PIII - Non applicable | Prospectus de base | BPWO-20232811-EN-DOCREG-2023-000317-02.pdf | |
| 19/09/2023 | Inver Invest | Divers | Prospectus complet | 2023-(1145)-FR-SCS20230259-A01-B25-C01-NP-CD19_09.pdf | |
| 05/09/2023 | CRELAN | PIII - Non applicable | Supplément au prospectus | SUPP-20230809-EN-DOCREG-2023-000294-02.pdf | |
| 22/08/2023 | KBC Groupe | PIII - Instrument de dette dont la valeur nominale unitaire s’élève au moins à 100 000 EUR | Prospectus complet | STDA-20230409-EN-DOCREG-2023-000327-03.pdf | |
| 22/08/2023 | BNP Paribas Fortis | PIII - Non applicable | Prospectus de base | BPWO-20230809-EN-DOCREG-2023-000182-02.pdf | |
| 22/08/2023 | BNP Paribas Fortis | PIII - Non applicable | Prospectus de base | BPWO-20230809-EN-DOCREG-2023-000185-02.pdf | |
| 22/08/2023 | Oxurion | Actions | Supplément au prospectus | SUPP-20232208-EN-DOCREG-2023-000306-03.pdf | |
| 22/08/2023 | Febelco | Actions | Prospectus complet | STDA-20232408-NL-DOCREG-2023-000311-03.pdf | |
| 22/08/2023 | Casa Kafka Pictures | Divers | Prospectus complet | 2023-(1102)-FR-SCS20230234-A01-B25-C01-NP-CD22_08.pdf | |
| 22/08/2023 | uFund | Divers | Supplément au prospectus | 2023-(1128)-FR-SCS20230260-A01-B25-C11-NP-CD22_08.pdf | |
| 22/08/2023 | Scope Invest | Divers | Supplément au prospectus | 2023-(1041)-FR-SCS20230252-A01-B25-C11-NP-CD22_08.pdf | |
| 01/08/2023 | Caviar Film Financing | Divers | Prospectus complet | 2023-(1142)-FR-NL-EN-SCS20230225-A01-B25-C01-NP-CD01_08.pdf | |
| 26/07/2023 | CRELAN | PIII - Non applicable | Prospectus de base | BPWO-20232807-EN-DOCREG-2023-000212-02.pdf | |
| 25/07/2023 | Sequana Medical | Actions | Prospectus complet | STDA-20231608-EN-DOCREG-2023-000296-03.pdf | |
| 25/07/2023 | MDxHealth | Actions | Prospectus complet | STDA-20232707-EN-DOCREG-2023-000288-03.pdf |